American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: General principles

摘要: Abstract Purpose To develop brachytherapy recommendations covering aspects of pretreatment evaluation, treatment, and dosimetric issues for locally advanced cervical cancer. Methods Members the American Brachytherapy Society (ABS) with expertise in cancer formulated updated (Federation Gynecology Obstetrics Stages IB2–IVA) based on literature review clinical experience. Results The ABS recommends use as a component definitive treatment carcinoma. Precise applicator placement is necessary to maximize probability achieving local control without major side effects. cumulative delivered dose approximately 80–90 Gy treatment. point A should be reported all applications regardless treatment-planning technique. also adoption Groupe Europeen Curietherapie-European Therapeutic Radiation Oncology (GEC-ESTRO) guidelines contouring, image-based planning, reporting. Interstitial may considered small proportion patients whose disease cannot adequately encompassed by intracavitary application. It performed practitioners special these procedures. Conclusions Updated are provided Practitioners cooperative groups encouraged formulate their practices adopt dose-reporting policies that critical outcome analysis.